Case Study: Catalent Pharma Solutions improves portfolio prioritization with SmartOrg Portfolio Navigator

Catalent Pharma trims a 100-project portfolio to 60 with SmartOrg

Catalent Pharma Solutions, a pharmaceutical company with over $1.7 billion in annual revenue, faced a challenge in managing its large portfolio of over 100 development projects. They needed a better way to evaluate which projects to continue or end and how to best allocate their R&D resources to maximize value. To address this, they turned to vendor SmartOrg and its Portfolio Navigator enterprise software.

By implementing SmartOrg's Portfolio Navigator, Catalent gained the ability to make more informed portfolio decisions. The solution enabled them to quickly identify and end 40 underperforming projects while providing additional support to 60 promising ones. According to their VP of Global Innovation, the software provided advanced project-management capabilities and became a huge asset, dramatically improving their efficiency and ability to manage the pipeline.

Catalent Pharma